Researchers create groundbreaking first-draft map of genetic interactions within human cells
On Apr. 30, 2026, researchers at the University of Bonn and University Hospital Bonn have created a groundbreaking…
-
-
UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patients
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
-
CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Measles | Vaccine
Harsh Flu Season May Be Driven by New Variant K
On Dec. 16, 2025, researchers from the International Vaccines Access Center (IVAC) reported that as of mid-December, flu,…
-
Agriculture | Artificial Intelligence | Biotechnology | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Canada launches $1.7 billion initiative to recruit world-leading researchers
On Dec. 9, 2025, officials from the Canada Economic Development for Quebec Regions, and the Minister of Industry,…
-
Biotechnology | CDC | COVID-19 | Infectious Disease | Measles | Vaccine
Canada Loses Measles Elimination status after three decades
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…
-
McGill physicists manoeuvre DNA molecules using electrical fields
On Oct. 2, 2025, researchers in McGill’s Department of Physics announced they have developed a new device that can trap…
-
Moderna’s UK Manufacturing Facility Received Manufacturing License from the MHRA
On Apr. 15, 2025, Moderna announced that its manufacturing facility in Harwell, Oxfordshire, the Moderna Innovation and Technology…
-
Study uncovers key role of RNA modifications in prostate cancer progression
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
-
AquaBounty Announced Plans to Cease Fish Farming Operations
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
-
Agriculture | Genomics | USDA
USDA, university researchers develop near chromosome-level genome for the Mojave Poppy bee
On May 2, 2024, scientists at the U.S. Department of Agriculture’s (USDA) Agricultural Research Service (ARS) and university…
-
Hugel Received FDA Approval in the U.S. of Letybo (letibotulinumtoxinA-wlbg) for Injection for Treatment of Glabellar Lines
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
-
Biotechnology | Disease | FDA | Therapeutics
Vertex announced U.S. FDA approval for TRIKAFTA in children with cystic fibrosis ages 2 through 5 with certain mutations
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
-
Biotechnology | Cardiology | Clinical Research | Disease | HIV | NIH | Non-Profit Research
Daily statin reduced the risk of cardiovascular disease in people living with HIV, large NIH study found
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
-
Climate warming and increasing Vibrio vulnificus infections in North America
On Mar. 23, 2023, a study published in Scientific Reports warned that vibrio vulnificus is an increasingly recognized…
-
Federal investment to increase Canada’s capacity to develop and manufacture critical medicines
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
-
Health Canada authorized Moderna’s Omicron-targeting bivalent COVID-19 vaccine in children & Adolescents
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
-
Biotechnology | Diagnostics | Disease | Medical Device | Nanotechnology | Non-Profit Research | Therapeutics
British Columbia Institute of Technology received $14.5 million to support aerospace and life sciences training
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
-
Moderna received Health Canada authorization for second Omicron-targeting bivalent booster
On Nov. 3, 2022, Health Canada authorized an adapted version of the Moderna Spikevax COVID-19 vaccine that targets…
-
Moderna finalized plan for long-term strategic partnership with the Government of Canada
On Apr. 29, 2022, Moderna announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec…
-
Highly pathogenic avian influenza reported in Alberta
On Apr. 12, 2022, the Province of Alberta poultry reported that farms had tested positive for highly pathogenic…
-
Health Canada authorized Moderna’s COVID-19 vaccine in children (6-11 Years)
On Mar. 17, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…
-
USDA confirmed COVID-19 in a Canada lynx at a Pennsylvania zoo
On Dec. 21, 2021, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratories announced confirmation of…
-
Construction of the Biologics Manufacturing Centre in Montreal completed
On Jun. 22, 2021, the National Research Council of Canada (NRC) announced it had completed construction of the…
-
CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling review
On Apr. 19, 2021, CytoDyn announced it had submitted the manufacturing section (CMC) of the application for an…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science History | Therapeutics | Vaccine
Altasciences partnered with NRC of Canada to qualify quantitative serological assay for detection of SARS-CoV-2 IgG antibodies
On Mar. 17, 2021, Altasciences working with the National Research Council of Canada (NRC), announced that it had…
-
DNA Genotek’s OMNIgene ﾷORAL saliva collection device received Health Canada Authorization for COVID-19 testing
On Jan. 28, 2021, OraSure Technologies announced its OMNIgene®·ORAL (OME-505) saliva collection device, a product of Ottawa-based subsidiary…
-
National Research Council of Canada supported development of 4 COVID-19 therapeutic candidates
On Dec. 18, 2020, the National Research Council of Canada (NRC) announced it was providing advisory services and…
-
Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacity
On Dec. 15, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
-
Edwards HemoSphere platform receives expanded use indication from Health Canada in treatment of COVID-19 patients
On Apr. 27, 2020, Edwards Lifesciences announced that Health Canada approved an expanded indication for use of the…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
